As one of the exhibitors, Zhejiang Kinso Technology Co., Ltd. (hereinafter referred to as "Kinsotech") participated in this prestigious global pharmaceutical event, showcasing its strong capabilities in specialty medicines, pesticides, and material intermediates to industry professionals from around the world.
At the exhibition, Kinsotech, recognized as one of the leading domestic exporters of pharmaceutical intermediates, displayed key products including 4-Bromo-2-fluoroaniline (CAS：367-24-8), 3-Amino-5-mercapto-1,2,4-triazole (CAS：16691-43-3), 1,3,5-Trimethoxybenzene (CAS：621-23-8), 2-Chloro-4-fluorobenzoic acid (CAS：2252-51-9), Nonaethylene glycol (CAS：3386-18-3). These flagship products attracted considerable attention from international buyers, positioning Kinsotech as a standout participant at the event.
As an internationally oriented pharmaceutical enterprise, Kinsotech has consistently adhered to the core values of "Survive by quality, Develop by innovation, Win-win by integrity." Following the successful conclusion of the exhibition, Kinsotech promptly activated a rapid response mechanism to address customer inquiries, established a dedicated service team, and made every effort to follow up on potential collaborations, ensuring that client needs were met efficiently and accurately.
At CPHI China 2025, Kinsotech effectively demonstrated its comprehensive strength within the pharmaceutical industry, reinforcing its global strategic partnerships. Looking ahead, Kinsotech is committed to collaborating with international partners to explore new frontiers in pharmaceutical technology. The company warmly invites global collaborators to join hands in advancing shared goals and looks forward to reuniting at CPHI China 2026 to co-create a new chapter of success.
